Robuta

Second pair of Fibronectin type III domains of integrin beta4 bound to the bullous pemphigoid antigen BP230 (BPAG1e)

Monoclonal antibodies (mAb) targeting immune checkpoint pathways such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed death 1 (PD-1) may...

Key Bullous Pemphigoid Treatment Market Trends Shaping the Industry The Bullous Pemphigoid Treatment Market trends indicate a growing focus on biologics,...